Delivery Order SPE2DB20D3101-SPE2DB22FK5K5
- Not listed
- This federal contract award, valued at $2,353.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
- This federal contract award, valued at $32,954.82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,563,850 units of Tadalafil 20 mg tablets, a medication used to treat various medical conditions. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The $2,014.59 firm fixed price delivery order is for the supply of 4,564,147,104 units of the drug Tadalafil 20 mg tablets in 30-count packages. The award is part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, valued at up to $999,999,999.00, which serves as the primary...
- This federal contract award, valued at $6,077.20, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,975,200 tablets of tadalafil 10 mg, a medication used to treat various medical conditions. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 21, 2025. It is not designated as a set-aside...
- This federal contract award, valued at $52,127.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for 4,566,929,547 units of Tadalafil 20 mg Tablets, a medication used to treat various medical conditions. The contract has a Firm Fixed Price pricing type and an ultimate completion date of January 15, 2025. This award is not designated as a set-aside contract....
- This federal contract award, valued at $155,346.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4563829008 Tadalafil 20 mg tablets in 30-count packaging. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 4, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $1,392.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Tadalafil 5 mg tablets in quantities of 30 tablets per bottle. This contract does not have a set-aside designation, indicating it was awarded through open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award is a delivery order valued at $1,328.64 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4562316251 Tadalafil 5 mg tablets. The award has an ultimate completion date of September 27, 2023, and is a firm fixed-price contract. There is no set-aside designation indicated. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,199.21 firm fixed-price delivery order is for the supply of 4,566,676,182 units of Tadalafil 5 mg tablets. The contract has an ultimate completion date of December 11, 2024 and was awarded on December 10, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, provides for the delivery of 4,564,860,519 units of the prescription medication tadalafil 5 mg tablet. The $1,169.08 firm fixed price delivery order contract was awarded on June 10, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, with a completion date of June 11, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB22FK5K5Delivery Order
This federal contract award, valued at $3,274.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract delivers Tadalafil 20mg tablets, a prescription medication used to treat various medical conditions. This order does not have a set-aside designation, indicating open competition. Amerisourcebergen, as the prime contractor, is responsible for supplying this pharmaceutical product to support military healthcare programs, veterans' healthcare, and other federal medical institutions. The company also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 8/2/22 |